Sign in with Google+ Sign in with LinkedIn

Best test for Lyme & Co-infections

Best test for Lyme co-infections
Should Lyme patients be concerned about Bartonella? Commonly associated with Cat Scratch Disease (CSD), this bacteria is also commonly included in the toxic waste dumped into the human bloodstream via a tick or flea bite.

If you have a diagnosis of Lyme disease, you should be aware that you may also be dealing with common co-infections such as Babesiosis, Ehrlichsiosis, or Bartonellosis. Get tested and treated for these additional inflictions, which can cause symptoms and impact the immune-system.

What are some of the problems associated with co-infections? Well, it begins with not even knowing that you might have them. Not all diagnostics labs are created equal. We admire the work that is being done at IGeneX. Here are some of the reasons why.

Same old Lyme-testing trouble
Nick S. Harris, PhD., of IGeneX laboratory in Palo Alto, CA, cautions that due to many factors, Lyme disease remains very complicated to correctly diagnose. Among the top reasons stated, infection does not show up the same in everybody. People all react differently. In addition, seralogical (blood) tests yield unreliable results because the Lyme bacteria is known for its stealth activity and it likes to hide. Lyme is weird (you heard it here). Even in a person with active disease, the bacteria are not always likely to be detectable in the blood. On top of that, antibodies may only be present for a short amount of time, making testing for Lyme bacterial infection a hit-and-miss affair at best.

Standard tests frequently flunk
If you go to your IDSA doctor, assuming you can convince them to test you for Lyme, he or she will give you the standard ELISA and Western Blot Lyme tests recommended by the CDC. What your doctor may or may not know is that these standard tests often fail to give positive diagnoses to patients, causing a chain of reaction wherein they are not made aware that they should begin proper treatment for the disease.

This frustrating scenario has been going on for years. Decades. Your doctor or doctors might also be smart enough to be paying attention to what many call the Lyme wars. They might recognize that while a positive blood test would be optimal, where Lyme is concerned, a clinical diagnosis is often the only way that doctors can observe your condition.

More sensitive testing required
IGeneX lab offers tests sensitive enough to detect the bacteria. For many Lyme patients, myself included, testing at IGeneX has signified the end of the mystery (do I have Lyme?), and the beginning of recovery.

Dr Harris recommends that “for patients presenting with clinical symptoms of Lyme Disease who test negative by the IgG or IgM Western Blot, the Whole Blood PCR or the LDA/Multiplex PCR Panel on urine may be appropriate. There are physician-developed antibiotic protocols to enhance the sensitivity of the LDA. In addition, there seems to be increased sensitivity of this test during the start of menses.”

IGeneX tests for Co-infections
IGeneX lab also offers tests for other tick-borne illnesses. The following info is from Dr Harris on their website:

“The tests are IFA (fluorescent antibody) or direct tests by PCR. In the case of
Babesia, FISH (fluorescent in situ hybridization) is also available. The FISH test detects the ribosomal RNA of the Babesia parasites directly on air-dried blood smears. This test is highly specific for Babesia, unlike the standard test, the geimsa stain smear, which cannot differentiate between malaria parasites and Babesia.”

Babesiosis Tests
B. Microti and/or WA-1 IgG/IgM Antibody Babesia and/or Babesia WA-1 PCR Babesia FISH (RNA)

Ehrlichiosis Tests
Human Granulocytic Ehrlichia IgG/IgM Antibody Human Granulocytic Ehrlichia PCR Human Monocytic Ehrlichia IgG/IgM AntibodyHuman Monocytic Ehrlichia PCR

Bartonella Tests
Bartonella henselae PCR with Whole Blood

New Bartonella Test
Across the country, another diagnostics lab has been working on a new test for Bartonella, and they want you to know about it so you can request it from your doctor. Galaxy Diagnostics in Research Triangle Park, NC, claims it has developed an even more sensitive test for Bartonella, using state-of-the-art molecular detection.

According to their literature, twenty-eight species of Bartonella have been identified so far, and new species are found every year.

Added cost, but better long-term health prognosis
Of course, testing for co-infections will likely add cost to your treatment plan. But it is important to know what obstacles you could be facing on the road back to good health.


New Lyme test available in Europe

A new test that detects the Borrelia infection is now available in Europe. I hope to find out whether this novel test will become available in the US anytime soon.

SpiroFind was developed in Mellrichstadt, Germany by the European subsidiary of Boulder Diagnostics, a privately owned company in Colorado that focuses on diagnosing diseases that are not reliably diagnosed.

The SpiroFind test detects Borreliosis through each stage, from early to late or chronic manifestation. It works by measuring the immune response to the Borrelia bacteria. Europeans may now contact the clinical laboratory, which is accepting blood samples for testing.

The effectiveness of the SpiroFind test was confirmed in a clinical study at the
Radboud University Nijmegen Medical Centre in the Netherlands. Conclusions of the study have been submitted for peer-reviewed publication and presentation at a conference in Berlin, Germany in April 2013.

DNA Test in US Available
new Lyme disease test, which tests DNA, became available in the US in 2010. I talked to Dr. Sin Hang Lee about this test, which is available in Milford, Connecticut. Patients and physicians interested in information on this DNA test may call George Poole, manager of Milford Medical Laboratory, at 203-876-4496.

New diagnostic tools give us hope for earlier and more effective treatment.


NIH develops more sensitive test for Lyme disease

Reported in the June, 2010 issue of Clinical and Vaccine Immunology:

New Test May Simply and Rapidly Detect Lyme Disease

Researchers from the National Institutes of Health have developed a more sensitive test for Lyme disease that may offer earlier detection and lower cost. The details are reported in the June 2010 issue of the journal Clinical and Vaccine Immunology.

Lyme disease is a bacterial infection transmitted to animals and humans by deer ticks. A skin lesion at the site of the bite is one of the first signs of infection followed by potential neurological, cardiac, and rheumatological complications upon entering the bloodstream. The Centers for Disease Control and Prevention currently recommends a two-step blood test for diagnosing the disease, however, several limitations include low sensitivity during the early stages of infection, significant time and expense, and an inability to distinguish between active and prior infection.
In prior studies the luciferase immunoprecipitation system (LIPS) test showed promise at detecting a variety of infectious agents including viral and fungal pathogens. Here, LIPS was evaluated for its ability to detect antibody responses to Borrelia burgdorferi proteins in blood samples taken from a patient group (some healthy and some with Lyme disease) as well as a control group. Results showed that diagnostic levels of 98% to 100% were achieved using LIPS in conjunction with the synthetic protein VOVO.

"These results suggest that screening by the LIPS test with VOVO and other B. burgdorferi antigens offers an efficient quantitative approach for evaluation of the antibody responses in patients with Lyme disease," say the researchers.

(P.D. Burbelo, A.T. Issa, K.H. Ching, J.I. Cohen, M.J. Iadarola, A. Marques. 2010. Rapid, simple, quantitative, and highly sensitive antibody detection for Lyme disease. Clinical and Vaccine Immunology, 17. 6: 904-909.)

Want a Lyme test that looks for antigens?

"We have to go on," says Tom. "We can't change yesterday, but the thing that keeps us going is that sooner or later we're going to catch that bug in time, and save someone from going through this pain."

Tom was sick and suffering with mysterious symptoms for nine years before a test finally convinced one of his doctors that he did indeed have Lyme disease. At that point, he began taking antibiotics. In the first month, severe Herxheimer reactions made him even more ill than he had been without treatment, but he continued for five months. Three years later, he now feels better in most ways. Occasionally, he has bad days that he attributes to the Lyme bug, but feels that for the most part, it is suppressed.

"I thought I was dying," he says. Hit by a massive anxiety attack while driving through Kansas, he experienced such debilitating vertigo that he had to pull the car over to the side of the road. "Everything was spinning wildly around me."

"I had lost track of the number of doctors I went to for help over those nine years. One doctor in Massachusetts, who I knew thought I was crazy finally told me that he thought I was crazy. He told me there was nothing wrong with me, and recommended psychiatric help."

"He told me that he thought I was an 'attention-seeker'."

I said to him, "Look, doc. I'm a concert pianist and a concert organist. If I want attention, all I have to do is book a recital. I don't need attention from you."

The test that finally clinched the correct diagnosis for Tom is a special kind of technique called Flow Cytometry. It is available at the Central Florida Research Laboratory, located in Winter Haven, FL. Instead of looking for the antibodies that build up in response to a Lyme Borreliosis infection, the Flow Cytometry technique finds the Borreliosis antigens directly.

Since Spring 2007, the CFR lab has tested several thousand people for Lyme disease. Blood samples arrive from locations all over the globe,  including all over Europe, where Lyme disease is known simply as Borreliosis.

In addition to testing people, CFR also tests animals for Lyme. Please refer to the CFR website for more information about the Flow Cytometric Lyme test for pets and people.

Central Florida Research Laboratory
Winter Haven, FL
Medical Director: Clifford H Threlkeld, DO, FCAP
Phone Number: (863) 299-3232
Fax Number: (863) 299-3355

New Lyme test for early detection

Here's a piece of good news. If you live in the Lyme-endemic region of Milford, CT, you have a new option for testing. And -- unless you have Aetna -- your insurance plan should cover it.

Pathologist Sin Hang Lee, MD, and his team have developed a DNA test for early Lyme detection. Details are available in the American Journal of Clinical Pathology. The test is the first of its kind. I recently talked with Dr Lee about the new test, which has been in use at the Milford Hospital for about one year.

Early detection is extremely important. People who are diagnosed with Lyme in the early stage have a good chance of receiving treatment that will cure them, and they will have no further complications from the disease. The DNA test eliminates the false positives that are problematic in the traditional Lyme tests, specifically the Western Blot and the ELISA.

The test is good news for people in the Milford area who suspect they've been bitten by a tick. Reports from other regions in the NE, such as Portland, Maine, are already warning of an increase in tick bites this year.

According to the announcement of the new DNA Lyme test, "physicians at the Milford Hospital Emergency Center and Walk-in Urgent Care Center, who see about 40,000 patients a year, usually order the traditional antibody testing and the new DNA test for patients presenting with Lyme disease-like symptoms. Most insurance companies except Aetna will pay for the test."

Patients and physicians interested in information on this DNA test may call George Poole, manager of Milford Medical Laboratory, at 203-876-4496.

Listen to our interview with Dr. Sin Hang Lee about the Lyme DNA test.

Definitive Lyme test and Samento

Tests for Lyme seem to be deliberately confusing. Is there a definitive test or isn't there?

Dr. JoAnne Whitaker, Eleanor Fort and Lida Mattmann, PhD, have patented one. The Q-RiBb, which tests for antigens instead of antibodies is definitive because it locates actual Lyme bacteria in the body. Through the Bowen Research Lab in Florida, these physician/researchers have tested hundreds of people and found Lyme bacteria to be the cause of numerous misdiagnoses, among them MS, ALS, Parkinson's disease, fibromyalgia, CFIDS, rheumatoid arthritis and cardiac arrythmias. Dr. Whitaker has reason to suspect that Lyme is a pandemic that is being repressed by the medical-industrial complex.

People who have been misdiagnosed and subsequently treated for Lyme disease are getting well. The Lyme pathogen is hardy, tenacious and difficult to kill, but medical doctors with the courage to help their patients heal are finding holistic protocols that work. Samento, Cumanda and other Peruvian herbs, which have only become available in the US since 2001, are rising in popularity among the Lyme population, many of whom are quite sophisticated in finding ways to heal from a disease that the conventional medical community is too frightened to acknowledge.

For information about Samento and Cumanda, click here

Click here to join the LDRD and listen to our interview with Dr. Joanne Whitaker and many other Lyme literate physicians